Class information for:
Level 1: RIMONABANT//ENDOCANNABINOIDS//TARANABANT

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
8413 1255 46.4 87%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
497 3       CANNABINOID//ANANDAMIDE//ENDOCANNABINOIDS 22707
535 2             CANNABINOID//ENDOCANNABINOIDS//ANANDAMIDE 14838
8413 1                   RIMONABANT//ENDOCANNABINOIDS//TARANABANT 1255

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 RIMONABANT authKW 1331263 12% 35% 155
2 ENDOCANNABINOIDS authKW 373350 13% 9% 163
3 TARANABANT authKW 296579 1% 76% 16
4 SR141716 authKW 234622 3% 28% 35
5 ENDOCANNABINOID SYSTEM authKW 220448 5% 15% 59
6 CB1 RECEPTOR ANTAGONIST authKW 216742 1% 64% 14
7 CANNABINOID authKW 212185 14% 5% 175
8 CB1 ANTAGONIST authKW 207421 1% 47% 18
9 CB1 RECEPTOR authKW 206281 6% 11% 75
10 ENDOCANNABINOID GRP address 180857 5% 12% 60

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Endocrinology & Metabolism 4548 24% 0% 299
2 Chemistry, Medicinal 2096 13% 0% 159
3 Pharmacology & Pharmacy 1839 24% 0% 301
4 Nutrition & Dietetics 1666 10% 0% 127
5 Neurosciences 759 16% 0% 206
6 Behavioral Sciences 699 6% 0% 72
7 Chemistry, Organic 194 7% 0% 91
8 Psychiatry 160 5% 0% 65
9 Gastroenterology & Hepatology 105 4% 0% 45
10 Psychology, Biological 95 1% 0% 14

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ENDOCANNABINOID GRP 180857 5% 12% 60
2 PHYSIOL STUDIES 83265 3% 11% 32
3 UNIT INVEST 51489 1% 12% 18
4 DIABET METAB CLIN NUTR 48659 0% 100% 2
5 GRP PHYSIOPATHOL ADDICT 48659 0% 100% 2
6 NEURO MAGENDIE PHYSIOPHATOL PLASTICITE NEURONA 48659 0% 100% 2
7 TEAM PATHOPHYSIOL DYSLIPIDEMIA 48659 0% 100% 2
8 FDN IMABIS 48461 1% 12% 17
9 HOSP RIO HORTEGA 45797 1% 10% 18
10 MED REGENERAT 43920 1% 16% 11

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 OBESITY 5039 2% 1% 29
2 BEHAVIOURAL PHARMACOLOGY 4034 1% 1% 18
3 METABOLISMES HORMONES DIABETES ET NUTRITION 3739 0% 8% 2
4 INTERNATIONAL JOURNAL OF OBESITY 3632 3% 0% 32
5 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2641 4% 0% 53
6 JOURNAL OF MEDICINAL CHEMISTRY 1666 3% 0% 39
7 NUTRITION & DIABETES 1649 0% 2% 4
8 PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 1603 2% 0% 29
9 JOURNAL OF NEUROENDOCRINOLOGY 1479 1% 0% 14
10 BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM 1218 1% 1% 7

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 RIMONABANT 1331263 12% 35% 155 Search RIMONABANT Search RIMONABANT
2 ENDOCANNABINOIDS 373350 13% 9% 163 Search ENDOCANNABINOIDS Search ENDOCANNABINOIDS
3 TARANABANT 296579 1% 76% 16 Search TARANABANT Search TARANABANT
4 SR141716 234622 3% 28% 35 Search SR141716 Search SR141716
5 ENDOCANNABINOID SYSTEM 220448 5% 15% 59 Search ENDOCANNABINOID+SYSTEM Search ENDOCANNABINOID+SYSTEM
6 CB1 RECEPTOR ANTAGONIST 216742 1% 64% 14 Search CB1+RECEPTOR+ANTAGONIST Search CB1+RECEPTOR+ANTAGONIST
7 CANNABINOID 212185 14% 5% 175 Search CANNABINOID Search CANNABINOID
8 CB1 ANTAGONIST 207421 1% 47% 18 Search CB1+ANTAGONIST Search CB1+ANTAGONIST
9 CB1 RECEPTOR 206281 6% 11% 75 Search CB1+RECEPTOR Search CB1+RECEPTOR
10 CB1 180288 4% 13% 55 Search CB1 Search CB1

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 SHARMA, MK , MURUMKAR, PR , KANHED, AM , GIRIDHAR, R , YADAV, MR , (2014) PROSPECTIVE THERAPEUTIC AGENTS FOR OBESITY: MOLECULAR MODIFICATION APPROACHES OF CENTRALLY AND PERIPHERALLY ACTING SELECTIVE CANNABINOID 1 RECEPTOR ANTAGONISTS.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 79. ISSUE . P. 298 -339 138 68% 16
2 SILVESTRI, C , DI MARZO, V , (2013) THE ENDOCANNABINOID SYSTEM IN ENERGY HOMEOSTASIS AND THE ETIOPATHOLOGY OF METABOLIC DISORDERS.CELL METABOLISM. VOL. 17. ISSUE 4. P. 475-490 104 72% 85
3 JANERO, DR , LINDSLEY, L , VEMURI, VK , MAKRIYANNIS, A , (2011) CANNABINOID 1 G PROTEIN-COUPLED RECEPTOR (PERIPHERO-)NEUTRAL ANTAGONISTS: EMERGING THERAPEUTICS FOR TREATING OBESITY-DRIVEN METABOLIC DISEASE AND REDUCING CARDIOVASCULAR RISK.EXPERT OPINION ON DRUG DISCOVERY. VOL. 6. ISSUE 10. P. 995 -1025 139 55% 6
4 SILVESTRI, C , DI MARZO, V , (2012) SECOND GENERATION CB1 RECEPTOR BLOCKERS AND OTHER INHIBITORS OF PERIPHERAL ENDOCANNABINOID OVERACTIVITY AND THE RATIONALE OF THEIR USE AGAINST METABOLIC DISORDERS.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 21. ISSUE 9. P. 1309 -1322 84 75% 33
5 BENNETZEN, MF , (2011) INVESTIGATIONS OF THE ENDOCANNABINOID SYSTEM IN ADIPOSE TISSUE EFFECTS OF OBESITY/WEIGHT LOSS AND TREATMENT OPTIONS.DANISH MEDICAL BULLETIN. VOL. 58. ISSUE 4. P. - 121 59% 5
6 CHOI, EB , PAK, CS , LEE, HK , (2009) THE CURRENT STATUS AND FUTURE PERSPECTIVES OF STUDIES OF CANNABINOID RECEPTOR 1 ANTAGONISTS AS ANTI-OBESITY AGENTS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 9. ISSUE 6. P. 482 -503 80 73% 57
7 GATTA-CHERIFI, B , COTA, D , (2016) NEW INSIGHTS ON THE ROLE OF THE ENDOCANNABINOID SYSTEM IN THE REGULATION OF ENERGY BALANCE.INTERNATIONAL JOURNAL OF OBESITY. VOL. 40. ISSUE 2. P. 210 -219 76 67% 1
8 QUARTA, C , MAZZA, R , OBICI, S , PASQUALI, R , PAGOTTO, U , (2011) ENERGY BALANCE REGULATION BY ENDOCANNABINOIDS AT CENTRAL AND PERIPHERAL LEVELS.TRENDS IN MOLECULAR MEDICINE. VOL. 17. ISSUE 9. P. 518 -526 66 81% 35
9 SCHEEN, AJ , (2009) THE ENDOCANNABINOID SYSTEM: A PROMISING TARGET FOR THE MANAGEMENT OF TYPE 2 DIABETES.CURRENT PROTEIN & PEPTIDE SCIENCE. VOL. 10. ISSUE 1. P. 56 -74 85 63% 17
10 CRISTINO, L , BECKER, T , DI MARZO, V , (2014) ENDOCANNABINOIDS AND ENERGY HOMEOSTASIS: AN UPDATE.BIOFACTORS. VOL. 40. ISSUE 4. P. 389 -397 58 69% 19

Classes with closest relation at Level 1


Rank Class id link
1 241 CANNABINOID//CANNABINOID RECEPTORS//CB2 RECEPTOR
2 651 CANNABINOID//CB1 RECEPTOR//ENDOCANNABINOIDS
3 2851 ANANDAMIDE//FATTY ACID AMIDE HYDROLASE//N ACYLETHANOLAMINE
4 17994 SEZ F BOTTAZZI//SEZ BOTTAZZI//DIPARTIMENTO STUDI
5 7029 SIBUTRAMINE//ORLISTAT//LORCASERIN
6 9204 MEDICAL MARIJUANA//CANNABIS//SATIVEX
7 18518 PYRAZOLE//WITHASOMNINE//3 ALKOXYPYRAZOLE
8 6960 HYPOTHALAM//HYPOTHALAMUS//LEPTIN RESISTANCE
9 10115 NOR BINALTORPHAMINE//MINNESOTA OBES//SWEET SUBSTANCE INDUCED ANTINOCICEPTION
10 29527 2 ARACHIDONOYLGLYCEROL ANANDAMIDE//ANANDAMIDE TRANSPORT INHIBITORS//ANTIGLAUCOMA ACTIVITY

Go to start page